Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Diseases, Bacterial | 2 | 2020 | 67 | 1.240 |
Why?
|
Poxviridae Infections | 1 | 2024 | 11 | 0.940 |
Why?
|
Orthopoxvirus | 1 | 2024 | 11 | 0.930 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2023 | 125 | 0.780 |
Why?
|
Vulvar Neoplasms | 1 | 2024 | 263 | 0.770 |
Why?
|
Lymphoma, T-Cell | 1 | 2023 | 304 | 0.730 |
Why?
|
Myasthenia Gravis | 1 | 2023 | 214 | 0.720 |
Why?
|
Myositis | 1 | 2023 | 269 | 0.700 |
Why?
|
Gram-Positive Bacteria | 1 | 2020 | 176 | 0.660 |
Why?
|
Gram-Negative Bacteria | 1 | 2020 | 271 | 0.620 |
Why?
|
Paronychia | 1 | 2018 | 10 | 0.620 |
Why?
|
Myocarditis | 1 | 2023 | 788 | 0.510 |
Why?
|
Fungi | 1 | 2018 | 338 | 0.490 |
Why?
|
Skin | 2 | 2020 | 4472 | 0.330 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4021 | 0.310 |
Why?
|
Mutant Chimeric Proteins | 1 | 2008 | 20 | 0.310 |
Why?
|
Cyclophilin A | 1 | 2008 | 58 | 0.300 |
Why?
|
vif Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 53 | 0.290 |
Why?
|
Cytosine Deaminase | 1 | 2007 | 66 | 0.290 |
Why?
|
Bacteria | 1 | 2018 | 2192 | 0.280 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7390 | 0.270 |
Why?
|
Retroviridae | 1 | 2008 | 851 | 0.250 |
Why?
|
Arctic Regions | 1 | 2024 | 26 | 0.230 |
Why?
|
Skin Neoplasms | 2 | 2022 | 5811 | 0.230 |
Why?
|
Scleroderma, Localized | 1 | 2023 | 87 | 0.210 |
Why?
|
Communicable Diseases, Emerging | 1 | 2024 | 148 | 0.200 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7403 | 0.190 |
Why?
|
Macaca mulatta | 1 | 2007 | 2328 | 0.180 |
Why?
|
Genital Neoplasms, Male | 1 | 2021 | 68 | 0.180 |
Why?
|
Aspergillus flavus | 1 | 2020 | 14 | 0.180 |
Why?
|
Paget Disease, Extramammary | 1 | 2021 | 51 | 0.180 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2022 | 212 | 0.170 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1880 | 0.160 |
Why?
|
Skin Care | 1 | 2018 | 56 | 0.160 |
Why?
|
Lymphoproliferative Disorders | 1 | 2022 | 531 | 0.160 |
Why?
|
Administration, Topical | 1 | 2020 | 703 | 0.150 |
Why?
|
HIV-1 | 4 | 2008 | 6858 | 0.150 |
Why?
|
Dermatomycoses | 1 | 2018 | 48 | 0.150 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2018 | 620 | 0.130 |
Why?
|
Primates | 2 | 2008 | 521 | 0.120 |
Why?
|
Guillain-Barre Syndrome | 1 | 2017 | 127 | 0.120 |
Why?
|
Taxoids | 1 | 2018 | 667 | 0.120 |
Why?
|
Skin Diseases | 1 | 2022 | 1094 | 0.110 |
Why?
|
Brachytherapy | 1 | 2021 | 1223 | 0.110 |
Why?
|
Infant, Premature, Diseases | 1 | 2018 | 710 | 0.100 |
Why?
|
Administration, Oral | 1 | 2020 | 4010 | 0.100 |
Why?
|
Dermatology | 1 | 2022 | 918 | 0.100 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20988 | 0.090 |
Why?
|
Paclitaxel | 1 | 2018 | 1730 | 0.090 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6305 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1400 | 0.080 |
Why?
|
Lentiviruses, Primate | 1 | 2008 | 7 | 0.080 |
Why?
|
Macaca nemestrina | 1 | 2008 | 21 | 0.080 |
Why?
|
Immunodeficiency Virus, Feline | 1 | 2008 | 11 | 0.080 |
Why?
|
Aotidae | 1 | 2008 | 58 | 0.080 |
Why?
|
Polynucleotide 5'-Hydroxyl-Kinase | 1 | 2007 | 7 | 0.070 |
Why?
|
Gene Products, vif | 1 | 2007 | 32 | 0.070 |
Why?
|
DNA Repair Enzymes | 1 | 2009 | 346 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 433 | 0.070 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1748 | 0.070 |
Why?
|
Species Specificity | 2 | 2008 | 2410 | 0.070 |
Why?
|
Retroelements | 1 | 2008 | 162 | 0.070 |
Why?
|
Sequence Alignment | 2 | 2008 | 2178 | 0.070 |
Why?
|
Virus Assembly | 1 | 2006 | 139 | 0.070 |
Why?
|
Humans | 16 | 2024 | 760740 | 0.060 |
Why?
|
Capsid | 1 | 2008 | 433 | 0.060 |
Why?
|
Capsid Proteins | 1 | 2008 | 464 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2023 | 80583 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13383 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1125 | 0.050 |
Why?
|
Models, Statistical | 1 | 2017 | 5074 | 0.050 |
Why?
|
DNA Repair | 2 | 2009 | 2043 | 0.050 |
Why?
|
Piperidines | 1 | 2009 | 1655 | 0.050 |
Why?
|
Animals | 4 | 2024 | 168202 | 0.040 |
Why?
|
Virus Replication | 1 | 2007 | 2427 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2008 | 13442 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3705 | 0.040 |
Why?
|
Skin Physiological Phenomena | 1 | 2018 | 188 | 0.040 |
Why?
|
Female | 3 | 2024 | 392203 | 0.040 |
Why?
|
Cell Membrane | 1 | 2006 | 3680 | 0.040 |
Why?
|
Cell Line | 2 | 2008 | 15577 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 2 | 2009 | 420 | 0.030 |
Why?
|
Puerto Rico | 1 | 2017 | 378 | 0.030 |
Why?
|
Protein Binding | 1 | 2008 | 9345 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5304 | 0.030 |
Why?
|
Proteins | 1 | 2008 | 6030 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22131 | 0.030 |
Why?
|
Long-Term Care | 1 | 2017 | 631 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2022 | 2218 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1257 | 0.020 |
Why?
|
Photoelectron Spectroscopy | 1 | 2009 | 12 | 0.020 |
Why?
|
DNA Polymerase beta | 1 | 2009 | 20 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9586 | 0.020 |
Why?
|
DNA Ligases | 1 | 2009 | 82 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4365 | 0.020 |
Why?
|
Circular Dichroism | 1 | 2009 | 344 | 0.020 |
Why?
|
Middle Aged | 2 | 2022 | 220603 | 0.020 |
Why?
|
Infant, Premature | 1 | 2018 | 2107 | 0.020 |
Why?
|
Etoposide | 1 | 2009 | 634 | 0.020 |
Why?
|
2-Naphthylamine | 1 | 2007 | 20 | 0.020 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2009 | 349 | 0.020 |
Why?
|
Forecasting | 1 | 2017 | 2924 | 0.020 |
Why?
|
Restriction Mapping | 1 | 2008 | 851 | 0.020 |
Why?
|
Xenopus Proteins | 1 | 2009 | 434 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3680 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2009 | 1692 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2597 | 0.020 |
Why?
|
Cricetulus | 1 | 2008 | 814 | 0.020 |
Why?
|
Gene Products, gag | 1 | 2006 | 312 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2007 | 544 | 0.020 |
Why?
|
Camptothecin | 1 | 2009 | 591 | 0.020 |
Why?
|
Male | 2 | 2021 | 360402 | 0.020 |
Why?
|
CHO Cells | 1 | 2008 | 1387 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 17630 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2006 | 695 | 0.010 |
Why?
|
Virion | 1 | 2006 | 422 | 0.010 |
Why?
|
Cricetinae | 1 | 2008 | 2424 | 0.010 |
Why?
|
Endosomes | 1 | 2006 | 522 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 1988 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2007 | 1790 | 0.010 |
Why?
|
Endocytosis | 1 | 2006 | 955 | 0.010 |
Why?
|
Biological Transport | 1 | 2006 | 2089 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6126 | 0.010 |
Why?
|
Protein Conformation | 1 | 2009 | 3965 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6051 | 0.010 |
Why?
|
Microtubules | 1 | 2006 | 1073 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5034 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3793 | 0.010 |
Why?
|
Cell Survival | 1 | 2009 | 5780 | 0.010 |
Why?
|
Kinetics | 1 | 2007 | 6370 | 0.010 |
Why?
|
Actins | 1 | 2006 | 2051 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2008 | 1894 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26183 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21339 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6520 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2008 | 5863 | 0.010 |
Why?
|
DNA Damage | 1 | 2007 | 2445 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36157 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12420 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 64572 | 0.010 |
Why?
|
Macrophages | 1 | 2006 | 5758 | 0.010 |
Why?
|
Models, Biological | 1 | 2007 | 9461 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2006 | 18937 | 0.010 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_